-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Epigenetic And Chromatin Mechanisms

Symposia: Scientific Workshop on Therapy Resistance Mechanisms in Blood Malignancies Program: Scientific Workshops
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Translational Research, Diseases, Lymphoid Malignancies, Myeloid Malignancies
Friday, December 6, 2024: 2:03 PM-2:44 PM
Room 33 (San Diego Convention Center)
Moderator:
and Panagiotis Ntziachristos, PhD, Ghent University
Disclosures:
No relevant conflicts of interest to declare.
The impact of epigenetic mechanisms in tumor cells and tumor microenvironment controlling resistance to therapy in myeloid and lymphoid malignancies will be discussed.
Moderator Introduction

Panagiotis Ntziachristos, PhD

Ghent University, Corneel Heymanslaan 10, Ghent, Belgium
Mechanisms of Gene Regulation By Chromatin Adaptors in Development and Disease

Yadira Soto-Feliciano, PhD

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA
Aberrant β-catenin Signaling from the Niche Transforms IDH1/2-Mutant Pre-malignant Stem Cells and Compromises Response to IDH1/2 Inhibitors

Stavroula Kousteni, PhD

Columbia University, New York, NY
Cooperation of Non-Genomic and Genomic Mechanisms of Persistence /Resistance to Pharmacological and Immune Based Therapies

Constantine S Mitsiades, MD

Dana-Farber Cancer Institute, Boston, MA
Panel Discussion
See more of: Scientific Workshop on Therapy Resistance Mechanisms in Blood Malignancies
See more of: Scientific Workshops
<< Previous Session | Next Session >>